Mitoxantrone and febrile neutropenia Patient Reports February 12, 2012

Mitoxantrone Side Effects Report #4836178-5
Mitoxantrone side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2005. Male patient, weighting 151.1 lb, was diagnosed with prostate cancer metastatic and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: febrile neutropenia, proteus infection, pseudomonas infection, sepsis . Mitoxantrone dosage: 12MG/M^2 Q3 WEEKS IV. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #5158983-0
Mitoxantrone side effect was reported by a Pharmacist from UNITED STATES on Nov 06, 2006. Male patient, 64 years of age, was diagnosed with prostate cancer  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: abdominal pain , acute myeloid leukaemia, blood bilirubin increased, chromosome analysis abnormal, febrile neutropenia, hypotension, hypoxia, lung infiltration, multi-organ failure. Mitoxantrone dosage: 12 MG/M2 Q3W. During the same period patient was treated with PREDNISONE, GOSERELIN, BICALUTAMIDE. Patient died.

Mitoxantrone Side Effects Report #5061445-2
Mitoxantrone side effect was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient, 66 years of age, was diagnosed with neoplasm malignant and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: febrile neutropenia. Mitoxantrone dosage: 20 MG ONCE. During the same period patient was treated with FLUDARABINE. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #4629859-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Mar 24, 2005. Female patient, 35 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, myelodysplastic syndrome. Mitoxantrone dosage: unknown. During the same period patient was treated with VENLAFAXINE, CLONAZEPAM, FOLIC ACID, DIHYDROERGOTAMINE MESYLATE, TROSPIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Mitoxantrone Side Effects Report #4649202-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Apr 13, 2005. Female patient, 35 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, white blood cell count decreased. Mitoxantrone dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with VENLAFAXINE, CLONAZEPAM, FOLIC ACID, DIHYDROERGOTAMINE MESYLATE, TROPSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #4692429-1
Mitoxantrone side effect was reported by a Consumer or non-health professional from on June 01, 2005. Female patient, 35 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, white blood cell count decreased. Mitoxantrone dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. During the same period patient was treated with VENLAFAXINE, CLONAZEPAM, FOLIC ACID, DIHYDROERGOTAMINE MESYLATE, TROSPIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #4680371-1
Mitoxantrone side effect was reported by a Health Professional from on May 19, 2005. Female patient, 21 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: febrile neutropenia, post procedural vomiting. Mitoxantrone dosage: 20 MG, 1 IN 1 CYCLE, INTRAVENOUS. Patient recovered.

Mitoxantrone Side Effects Report #5404973-X
Mitoxantrone side effect was reported by a Health Professional from UNITED STATES on July 25, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: agitation, aspergillosis, cerebral infarction, febrile neutropenia, hypertension, hypotension, lung infection pseudomonal, mucosal inflammation, oedema. Mitoxantrone dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient died on 03/14/2007.

Mitoxantrone Side Effects Report #5369645-9
Mitoxantrone side effect was reported by a Health Professional from UNITED STATES on June 14, 2007. Male patient, 22 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: central line infection, condition aggravated, febrile neutropenia, hypotension, oxygen saturation decreased, pleural effusion, pneumonia . Mitoxantrone dosage: 16.7 MG QD IV. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient recovered.


Mitoxantrone Side Effects Report #5695430-4
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2008. Female patient, 58 years of age, was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: febrile neutropenia, infusion site pruritus, rash erythematous. Mitoxantrone dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient recovered.